KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Intangibles (2016 - 2022)

Historic Change in Intangibles for TherapeuticsMD (TXMD) over the last 11 years, with Q4 2022 value amounting to $95000.0.

  • TherapeuticsMD's Change in Intangibles fell 9372.52% to $95000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $355000.0, marking a year-over-year decrease of 8378.25%. This contributed to the annual value of $355000.0 for FY2022, which is 8378.25% down from last year.
  • According to the latest figures from Q4 2022, TherapeuticsMD's Change in Intangibles is $95000.0, which was down 9372.52% from -$7000.0 recorded in Q3 2022.
  • Over the past 5 years, TherapeuticsMD's Change in Intangibles peaked at $1.5 million during Q4 2021, and registered a low of -$7000.0 during Q3 2022.
  • Its 5-year average for Change in Intangibles is $324120.4, with a median of $309762.0 in 2018.
  • Its Change in Intangibles has fluctuated over the past 5 years, first skyrocketed by 36441.72% in 2021, then tumbled by 10277.78% in 2022.
  • Quarter analysis of 5 years shows TherapeuticsMD's Change in Intangibles stood at $356501.0 in 2018, then rose by 4.76% to $373458.0 in 2019, then decreased by 12.71% to $326000.0 in 2020, then surged by 364.42% to $1.5 million in 2021, then tumbled by 93.73% to $95000.0 in 2022.
  • Its Change in Intangibles stands at $95000.0 for Q4 2022, versus -$7000.0 for Q3 2022 and $97000.0 for Q2 2022.